cell therapy
Researchers Test Single-Cell Whole-Genome Sequencing to Select Therapy in Relapsed Multiple Myeloma
Premium
At ASH's annual meeting, a study showed the potential for this method to inform the next treatment after patients relapse on BCMA- or GPRC5D-targeted therapy.
Celldom Lands $938K Phase II SBIR Grant From NCI
The grant will fund development of an application of Celldom's instrument for chimeric antigen receptor T-cell potency testing.
CellChorus Nabs $2.5M NIH SBIR Grant
A $350,000 Phase I grant is underway and a two-year $2.1 million Phase II grant will begin after CellChorus achieves certain predetermined milestones.
Metastatic Eye Cancer Immunogenomics Study Leads to Predictors of Immunotherapy Response
Researchers came up with a gene expression score for metastatic uveal melanoma cases that appeared to predict response to adoptive tumor infiltrating lymphocyte therapy.
Researchers Showcase New Scores, Biomarkers, Signatures for Predicting CAR T-Cell Outcomes at ASH
Premium
Across three studies, researchers demonstrated how various biomarkers can inform trial design and predict lymphoma patients' outcomes on CAR T-cell therapy.